Institut Curie (https://institut-curie.org) consists of a hospital and a world-class multidisciplinary research center combining research in cell biology, genetics, epigenetics, immunology, soft matter physics, organic and medicinal chemistry. It includes over 3,300 researchers, physicians, clinicians, technicians and administrative staff working on three sites: Paris, Orsay and Saint-Cloud. The institute facilities include an advanced imaging platform with a wide variety of top-of-the-line microscopes from confocal imaging to super-resolution, for live cell and small animal imaging. Other facilities include single cell technologies, small molecule and CRISPR screening, high throughput sequencing, bioinformatics, proteomics and mass spectrometry, antibody technologies and protein purification, nano-SIMS, cytometry, and animal housing (https://science.institut-curie.org/platforms). In addition, the hospital proximity allows access to large clinical databases and sample collections.
Institut Curie is supporting the recruitment of a junior group leader position, based at its research campus in central Paris in the “Cancer, Heterogeneity, Instability and Plasticity” unit https://science.institut-curie.org/research/integrated-biology/cancer-heterogeneity-instability-and-plasticity-chip/. The six research groups of the unit investigate basic mechanisms of cancer initiation, progression and/or resistance to treatment with particular focus on genetic and epigenetic alterations, tumor microenvironment, DNA repair and computational biology. Applications addressing molecular mechanisms of development of pediatric cancers, dynamics of cancer evolution and innovative therapeutics are welcomed.
We invite applications from outstanding candidates wishing to address questions on fundamental mechanisms of cancer development (“hallmarks of cancer”) using relevant model systems and/or investigating molecular bases of human malignancies. Important criteria for the selection of the candidates will be the outstanding quality of their scientific record and project, as well as their capacity to interface with biologists and clinicians in the department and beyond, and to drive developments in the field of biomedical research on cancer, the main mission of Institut Curie.
The newly recruited group will benefit from state-of-the-art research equipment. Appropriate laboratory space for 6-7 people and a start-up package will also be available. The successful candidate should meet the criteria to compete for national and international funding, and for French institutional research positions (University or INSERM).
Send full CV, motivation letter, 3-4 pages research plan and three reference letters to
For information please contact:
Olivier Delattre: , +33 156246679
Deadline for applications: February 15, 2021. Interviews scheduled in April 2021
Institut Curie is an inclusive, equal opportunities employer and is dedicated to the highest standards of research integrity.